Financhill
Back

EyePoint Plc 10K Form

Sell
48

EYPT
EyePoint Plc

Last Price:
$13.21
Seasonality Move:
19.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EYPT News And Ratings

See the #1 stock for the next 7 days that we like better than EYPT

EYPT Financial Statistics

Sales & Book Value

Annual Sales: $31.4M
Cash Flow: $-66M
Price / Cash Flow: 0
Annual Sales: $3.70
Price / Book: 3.6

Profitability

EPS (TTM): -3.16320
Net Income (TTM): $-232M
Gross Margin: $27M
Return on Equity: -83.61%
Return on Assets: -68.31%

EyePoint Plc Earnings Forecast

Key EyePoint Plc Financial Ratios

  • The Gross Profit Margin over the past 20 years for EYPT is 86.05%.
  • The Selling, General & Administrative Expenses for EYPT have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 704.60% of Revenue.
  • The Net Earning history of EYPT is -739.42% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 11 years.

EyePoint Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EYPT
CUSIP: 30233G
Website: eyepointpharma.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 8.88
Quick Ratio: 8.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EYPT Technical Analysis vs Fundamental Analysis

Sell
48
EyePoint Plc (EYPT) is a Sell

Is EyePoint Plc a Buy or a Sell?

  • EyePoint Plc stock is rated a Sell
    The current EyePoint Plc [EYPT] share price is $14.92. The Score for EYPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.